Skip to content
ArgusBio

Provider profile

Celonic.

Biologics CDMOs

Celonic documents cell line development (CHO), process and analytical development and GMP drug substance manufacturing for monoclonal antibodies, bispecifics and fusion proteins, from clinical supply to commercial manufacturing. It lists its headquarters and development center in Basel, Switzerland, and single-use GMP manufacturing in Heidelberg, Germany.

Website
celonic.com (opens in a new tab)
Sources reviewed
November 3, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Analytical development and QC testing2
  • Cell line development1,2,3
  • GMP drug substance manufacturing3Drug substance only; the company states fill and finish is offered via a third-party strategic alliance partner
  • Process development1,2
  • Stability studies2Stated as part of analytical method development
  • Technology transfer1,4Listed among Basel Biologics Development Center services

Platforms and methods

  • Mammalian cell culture2
  • Single-use bioreactors1Stated for the Heidelberg small-scale asset; the mid-scale asset is listed as 6x2000L SUB

Drug substance / drug product

  • Drug substance3Drug substance only; the company states fill and finish is offered via a third-party strategic alliance partner

Development experience

Development experience

Development stage

  • Commercial1,3,5Commercial supply stated for the Heidelberg 6x2000L mid-scale asset
  • Phase 24Stated as Phase II resupply from the Heidelberg small-scale asset
  • Phase 34Stated as Phase III PPQ from the Heidelberg small-scale asset

Modality

  • Monoclonal antibodies3
  • Recombinant proteins2,6

Locations

Locations

  • Basel, Switzerland · Headquarters1
  • Heidelberg, Germany · Manufacturing site1Clinical and commercial GMP drug substance manufacturing (single-use bioreactors up to 1000L and 6x2000L)
  • Basel, Switzerland · Laboratory1Biologics Development Center: cell line, process and method development and non-GMP pilot scale (200L)

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • GMP / cGMP1Stated for the Heidelberg facility (EU GMP certification for biological active ingredients)

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Available capacity, slot timing and scale for your next campaign
  • Recent experience with your specific modality and expression system or chemistry
  • Regulatory inspection history of the specific site that would manufacture your product
  • Technology-transfer approach, timeline and who owns the resulting process knowledge
  • Analytical and QC release testing done in-house versus subcontracted
  • Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

Evidence and sources

  1. 1Sites & Capabilities - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Preclinical - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Home - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Clinical Supply - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Late Phase & Market Supply - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6The University Hospital Cologne (UHC), in collaboration with the German Center for Infection Research (DZIF) has selected the Celonic Group for process development and GMP manufacturing of a monoclonal antibody - Celonic – Beyond Biomanufacturing (opens in a new tab)Celonic · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.